KATIE JASCHKE: Open Payments
NPI 1689024861 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 25 payments from 10 companies in 2025. Trend: 2023 $1,388 · 2024 $2,521 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $153 |
| Impulse Dynamics (USA) Inc. | 1 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Novo Nordisk Inc | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 4 | $63 |
| PFIZER INC. | 1 | $25 |
| ABIOMED | 1 | $23 |
| Medtronic, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
Products named: Optimizer, WATCHMAN FLX, Wegovy, LEQVIO, FARAPULSE, ELIQUIS, CAMZYOS, VYNDAQEL.
Industry payments across MO — which companies pay providers there.
